Citigroup Portfolio holdings
Citigroup Inc., formed in 1998 through the landmark merger of Citicorp and Travelers Group, with roots tracing back to the 1812 founding of City Bank of New York, is a global financial powerhouse headquartered in New York City, managing trillions in assets. Operating in over 160 countries, Citigroup offers a broad spectrum of services, including consumer banking (via Citibank), investment banking, wealth management, and trading, serving millions of retail customers and major corporations, governments, and institutions worldwide. Under CEO Jane Fraser since 2021—the first woman to lead a major U.S. bank—Citigroup has focused on streamlining operations, exiting consumer banking in 13 markets to bolster its institutional and wealth management focus, while navigating post-2008 regulatory scrutiny and fines. Known for its vast global footprint and resilience through crises, Citigroup remains a key player in international finance, blending retail accessibility with high-stakes capital markets expertise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bank of America
BAC
|
+$349M |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$305M |
| 3 |
iShares Gold Trust
IAU
|
+$282M |
| 4 |
State Street SPDR S&P Regional Banking ETF
KRE
|
+$269M |
| 5 |
Blackrock
BLK
|
+$267M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$625M |
| 2 |
NVIDIA
NVDA
|
+$604M |
| 3 |
Tesla
TSLA
|
+$576M |
| 4 |
Microsoft
MSFT
|
+$552M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$357M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.55% |
| 2 | Financials | 7.82% |
| 3 | Consumer Discretionary | 7.65% |
| 4 | Communication Services | 5.12% |
| 5 | Healthcare | 5.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5126
Ovid Therapeutics
OVID
$480M
| $3.77K | ﹤0.01% |
11,411
-31,786
| -74% | -$9.58K |
|
5127
ALX Oncology
ALXO
$293M
| $3.74K | ﹤0.01% |
9,010
-15,701
| -64% | -$7.92K |
|
|
GAUZ
5128
Gauzy
GAUZ
$8.26M
| $3.73K | ﹤0.01% |
442
+68
| +18% | +$602 |
|
5129
Acumen Pharmaceuticals
ABOS
$173M
| $3.61K | ﹤0.01% |
3,115
-26,721
| -90% | -$28.7K |
|
5130
SES AI
SES
$198M
| $3.6K | ﹤0.01% |
4,054
-91,565
| -96% | -$76.8K |
|
5131
GeoVax Labs
GOVX
$4.06M
| $3.55K | ﹤0.01% |
+164
| New | +$4.09K |
|
5132
Pluri
PLUR
$20M
| $3.52K | ﹤0.01% |
+712
| New | +$3.29K |
|
|
RERE
5133
ATRenew
RERE
$1.01B
| $3.41K | ﹤0.01% |
1,031
| – | – |
|
5134
CBAK Energy Technology Ltd
CBAT
$66.5M
| $3.35K | ﹤0.01% |
+2,843
| New | +$2.56K |
|
5135
Nautilus Biotechnolgy
NAUT
$116M
| $3.34K | ﹤0.01% |
4,613
-29,140
| -86% | -$21.9K |
|
5136
China Yuchai International
CYD
$1.77B
| $3.32K | ﹤0.01% |
+139
| New | +$2.44K |
|
|
GBIO
5137
DELISTED
Generation Bio
GBIO
| $3.32K | ﹤0.01% |
1,036
-2,443
| -70% | -$9.41K |
|
5138
Schwab Fundamental International Small Company Index ETF
FNDC
$3.15B
| $3.28K | ﹤0.01% |
78
| – | – |
|
5139
Blink Charging
BLNK
$84.4M
| $3.21K | ﹤0.01% |
3,413
-74,508
| -96% | -$59.5K |
|
|
QIPT
5140
DELISTED
Quipt Home Medical
QIPT
| $3.2K | ﹤0.01% |
1,792
-24,668
| -93% | -$48.7K |
|
5141
Sportsman's Warehouse
SPWH
$47.2M
| $3.05K | ﹤0.01% |
+885
| New | +$1.98K |
|
|
VSEE
5142
DELISTED
VSEE HEALTH INC
VSEE
| $2.89K | ﹤0.01% |
+2,489
| New | +$2.85K |
|
|
ABPWW
5143
CALL
DELISTED
Abpro Holdings Warrant
ABPWW
| $2.88K | ﹤0.01% |
125,001
| – | – |
|
5144
Genprex
GNPX
$2.25M
| $2.87K | ﹤0.01% |
+11
| New | +$3.36K |
|
5145
Telefônica Brasil
VIV
$19.1B
| $2.87K | ﹤0.01% |
252
-43,522
| -99% | -$428K |
|
5146
Acquirers Small and Micro Deep Value ETF
DEEP
$28.3M
| $2.83K | ﹤0.01% |
+86
| New | +$2.65K |
|
5147
PIMCO Investment Grade Corporate Bond Index Exchange-Traded Fund
CORP
$1.58B
| $2.73K | ﹤0.01% |
28
+26
| +1,300% | +$2.49K |
|
5148
Q32 Bio
QTTB
$473M
| $2.71K | ﹤0.01% |
1,822
-2,580
| -59% | -$4.4K |
|
5149
MINISO
MNSO
$3.74B
| $2.7K | ﹤0.01% |
148
-137
| -48% | -$2.46K |
|
5150
Immuneering
IMRX
$300M
| $2.68K | ﹤0.01% |
796
| – | – |
|
Similar funds
Citigroup's Q2 2025 Portfolio in Review
As of Q2 2025, Citigroup held 6,003 positions worth $204B, up 4.1% from $196B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Citigroup withdrew a net $14.6B in Q2 2025, closing 377 positions and reducing 2,974 holdings. Its most notable exit was James Hardie Industries, an estimated $125M position sold in full.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 18% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Citigroup opened a new position in Amrize Ltd worth $114M.
- Citigroup's largest Q2 2025 buy was Amrize Ltd: 2,294,135 shares worth $114M.
- Citigroup added most to Bank of America in Q2 2025, an estimated $349M increase.
- Citigroup's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $625M.
- Citigroup fully exited James Hardie Industries in Q2 2025, selling an estimated $125M.
- Citigroup's ten largest holdings make up 20% of its $204B portfolio in Q2 2025.
- Citigroup opened 468 new positions and closed 377 in Q2 2025.
- Citigroup's portfolio value rose 4.1% quarter-over-quarter to $204B.
Based on Citigroup's 13F filing for Q2 2025, filed 11 Aug 2025.